Freeborn's Litigation Practice Group's Quarterly Litigation Update, Powerhouse Points. In this Issue: Illinois Supreme Court Holds Insurance Company Owed Duty to Defend Insured against Class-Action Lawsuit alleging Violations of the Biometric Information Privacy Act, Matthew T. Connelly As COVID-19 Conditions Improve, Is It Time for Litigators to Re-Evaluate The Use of Virtual Testimony?, Lillian Grappe Lamphere Cosmetics Containing CBD - How Regulated Should They Be?, Kimberly A. Beis Will TRIPS Waiver of IP Protection for COVID-19 Vaccines Serve Global Need?, Delphine Knight Brown
Written by Attorney Lillian Grappe Lamphere for the Summer 2021 Edition of Powerhouse Points, A Quarterly Litigation Update. Read the full issue here. Powerhouse Points: In-person proceedings in many courts remain canceled or postponed with courts continuing to rely on virtual proceedings as a substitute. Virtual testimony is not an equivalent substitute for live, in-person testimony. Procedural rules allow courts to accept testimony by contemporaneous remote transmission for good cause in compelling circumstances, provided appropriate safeguards are in place. There have been significant
Written by Partner Delphine Knight Brown for the Summer 2021 Edition of Powerhouse Points, A Quarterly Litigation Update. Read the full issue here. Powerhouse Points: Proposed TRIPS waivers of IP protection for COVID-19 vaccines apply to copyrights, industrial designs, patents and trade secrets. Compulsory IP licenses issued in past public health emergencies have not required the disclosure of trade secrets. Compulsory IP licenses may raise jurisdictional, constitutional and enforcement issues. Even with waiver of IP protections, vaccine production is extremely complex and manufacturers face
Companies that own or operate websites or mobile apps not optimized for use by disabled people may become targets of lawsuits under the Americans with Disabilities Act (“ADA”), a federal law requiring public places (which include the cyber realm) be accessible to disabled people. Several state and local laws mirror the ADA and even add statutory damages (California and New York are popular among the plaintiffs’ bar). Learn more in this Client Alert written by Freeborn partner Jeremy Richardson and attorney Joel B. Bruckman.
Written by Partner Kimberly A. Beis for the Summer 2021 Edition of Powerhouse Points, A Quarterly Litigation Update. Read the full issue here. Powerhouse Points: While the FDA has not explicitly banned CBD in cosmetics, it does maintain enforcement actions against companies that market their products incorrectly. The European Union has recently taken steps towards allowing CBD as an ingredient in cosmetics in its member states. Despite this progress, different states have different rules on CBD, and organizations that want to sell cosmetics nation-wide need to take into account these
Freeborn & Peters LLP welcomes Amanda C. Andrews, Jerome R. Crabtree, and Robert A. Sikorski to the firm’s Chicago office as attorneys in the Corporate Practice Group, with Amanda and Jerome also joining the firm’s Trust and Estates team.
On June 25, 2021, the United States Supreme Court strongly reinforced the rule that every plaintiff in an individual action, and each class member in a class action, must have suffered a concrete injury-in-fact in order to pursue a claim for monetary damages in federal court, even if the claim is for violation of federal statute and Congress has authorized the recovery of statutory damages.
Freeborn & Peters LLP is pleased to announce that the firm has elevated attorneys Jessica Kirkwood Alley, Katheleen A. Ehrhart and Jeffrey A. Rossman to Equity Partner and attorney Ann M. Zwick to Income Partner, effective January 1, 2022.